Immunic

A potential MS ‘game changer’ could bring more safety to the table — even against viruses
Pharma Voice
Tue, 08/13/24 - 11:28 am
Immunic
vidofludimus calcium
MS
multiple sclerosis
Immunic punts psoriasis, prostate cancer programs to narrow focus onto multiple sclerosis, celiac disease
Fierce Biotech
Thu, 04/6/23 - 10:01 am
Immunic
prostate cancer
psoriasis
MS
multiple sclerosis
celiac disease
The other shoe drops for Immunic
EP Vantage
Fri, 10/21/22 - 10:19 am
Immunic
IMU-935
psoriasis
After ulcerative colitis flop, Immunic regains some momentum with multiple sclerosis update
Fierce Biotech
Wed, 06/15/22 - 10:58 am
Immunic
MS
multiple sclerosis
ulcerative colitis
vidofludimus calcium
Immunic says its colitis failure won’t hamper MS program
BioWorld
Sun, 06/5/22 - 11:28 pm
Immunic
vidofludimus calcium
ulcerative colitis
Immunic's lead drug fails to impress in 2 separate trials — and it's blaming some of its woes on the pandemic
Endpoints
Thu, 02/18/21 - 09:48 pm
Immunic
clinical trials
pandemic
COVID-19
primary sclerosing cholangitis
IMU-838
Immunic's lead MS drug hits primary and key secondary endpoints in PhII, but questions remain
Endpoints
Mon, 08/3/20 - 10:22 am
Immunic
MS
multiple sclerosis
clinical trials
IMU-838
The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate
Yahoo/Benzinga
Sun, 07/28/19 - 11:48 pm
biotech
earnings
Immunic
Alkermes
Conatus
Aevi Genomic
Tricida
Curis
Ultragenyx
Leap Therapeutics
Cidara Therapeutics
Akcea
Spark Therapeutics
Eli Lilly
AnaptysBio
clinical trials